Hospital Universitário João de Barros Barreto

Belém, Pará 66073-005

1 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, NASH, Obesity, Overweight

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis — Completed